Overview

Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis

Status:
Completed
Trial end date:
1999-09-01
Target enrollment:
Participant gender:
Summary
To study the effect of long-term treatment with raloxifene, compared with placebo, on the rate of new vertebral fractures in osteoporotic postmenopausal women with and without existing vertebral fractures.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Raloxifene Hydrochloride